Human malignant mesothelioma (MM) cells overexpressing calreticulin, a Ca2+-binding protein critical for MM cell survival in vitro, show increased nuclear FAK and resistance to Defactinib in vitro [77]. The gene discussed is PTK2; the disease is Miyoshi myopathy.